Home NDC 55150-365 Amphotericin B
Product NDC 55150-365
11-digit product format 551500365
Labeler code 55150
Product ID 55150-365_9f45e5d9-6acd-491e-a80c-f07ecc6ac109
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Amphotericin B
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Eugia US LLC
Application ANDA214010
Marketing category ANDA
Marketing start 2022-11-17
Substance AMPHOTERICIN B
Active strength 50 mg/12.5mL
Pharmacologic classes Lipid-based Polyene Antifungal [EPC], Polyene Antifungal [EPC], Polyenes [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A214010-001 AMPHOTERICIN B AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A214010-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 3bdfa0b2c4d7…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A214010-001 AMPHOTERICIN B 50MG/VIAL INJECTABLE, LIPOSOMAL / INJECTION AB 2022-11-17 a50c72e98297…
Observed Orange Book normalized TE history# Additional Listing Data#
Finished product Yes
Brand name base Amphotericin B
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength AMPHOTERICIN B 50 mg/12.5mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 7XU7A7DROE Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 967385 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 55150-365-01 Amphotericin B 12.5 mL in 1 VIAL, SINGLE-DOSE INJECTION, POWDER, LYOPHILIZED, 12.5 2 55150-365-01 Amphotericin B 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 55150-365 AMPHOTERICIN B INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [EUGIA US LLC] 1 Current NDC, Legacy NDC, 2 package rows 20221123_6f24975c-5191-4fc2-a8da-e57358f8e154.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 55150-365-01 55150036501 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-365-01) / 12.5 mL in 1 VIAL, SINGLE-DOSE 2022-11-17 0000-00-00 No No Current